Evaluation of S100B, NSE, MBP and GFAP serum levels in children with attention deficit hyperactivity disorder

Hatice Çelik Yıldırım; Bürge Kabukçu Başay; Egem Burcu Ünal

Makale detayları

Evaluation of S100B, NSE, MBP and GFAP serum levels in children with attention deficit hyperactivity disorder

Yazarlar:

Hatice Çelik Yıldırım | Bürge Kabukçu Başay | Egem Burcu Ünal

Yayıncı:

Pamukkale University

Ana Başlıklar:

Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları

Dergi:

Pamukkale Tıp Dergisi Vol.18 Issue 2, pp.432-443

Belge Tipi:

Makale

Yayın Tarihi:

1/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001322761

pISSN:

1308-0865

Anahtar kelimeler:

Özet:

 Purpose: This study aimed to investigate serum levels of S100B protein, Neuron Specific Enolase NSE, Myelin Basic Protein MBP and Glial Fibrillary Acidic Protein GFAP that reflect glial and neural structure. To date, these proteins have been studied in neuropsychiatric diseases and relation with neuronal damage has been shown. However, there is no study that simultaneously evaluates the serum levels of these proteins in children with ADHD and compares them with healthy controls. Materials and methods: 44 children with ADHD and 37 healthy volunteers participated in the study. They were selected from children and adolescents aged 6-18 years who had no history of other medical or psychiatric diseases and had not used psychotropic drugs for the last six months. Levels of proteins were assessed by enzyme-linked immunosorbent assay ELISA. Results: Serum levels of S100B, NSE and GFAP were found to be statistically significantly higher in the ADHD group than in the control group p0.012, p0.000, p0.001, respectively. No significant difference was found in the intergroup comparison for MBP p0.181. Conclusion: Increased levels of S100B, NSE, GFAP may be an indicator of neuronal or glial changes in ADHD. Future studies combining serial measurements of these biochemical proteins with genetics and neuroimaging data are needed to evaluate the possible role of glial and neuronal damage in the etiopathogenesis of ADHD.

 Purpose: This study aimed to investigate serum levels of S100B protein, Neuron Specific Enolase NSE, Myelin Basic Protein MBP and Glial Fibrillary Acidic Protein GFAP that reflect glial and neural structure. To date, these proteins have been studied in neuropsychiatric diseases and relation with neuronal damage has been shown. However, there is no study that simultaneously evaluates the serum levels of these proteins in children with ADHD and compares them with healthy controls. Materials and methods: 44 children with ADHD and 37 healthy volunteers participated in the study. They were selected from children and adolescents aged 6-18 years who had no history of other medical or psychiatric diseases and had not used psychotropic drugs for the last six months. Levels of proteins were assessed by enzyme-linked immunosorbent assay ELISA. Results: Serum levels of S100B, NSE and GFAP were found to be statistically significantly higher in the ADHD group than in the control group p0.012, p0.000, p0.001, respectively. No significant difference was found in the intergroup comparison for MBP p0.181. Conclusion: Increased levels of S100B, NSE, GFAP may be an indicator of neuronal or glial changes in ADHD. Future studies combining serial measurements of these biochemical proteins with genetics and neuroimaging data are needed to evaluate the possible role of glial and neuronal damage in the etiopathogenesis of ADHD.

 Purpose: This study aimed to investigate serum levels of S100B protein, Neuron Specific Enolase NSE, Myelin Basic Protein MBP and Glial Fibrillary Acidic Protein GFAP that reflect glial and neural structure. To date, these proteins have been studied in neuropsychiatric diseases and relation with neuronal damage has been shown. However, there is no study that simultaneously evaluates the serum levels of these proteins in children with ADHD and compares them with healthy controls. Materials and methods: 44 children with ADHD and 37 healthy volunteers participated in the study. They were selected from children and adolescents aged 6-18 years who had no history of other medical or psychiatric diseases and had not used psychotropic drugs for the last six months. Levels of proteins were assessed by enzyme-linked immunosorbent assay ELISA. Results: Serum levels of S100B, NSE and GFAP were found to be statistically significantly higher in the ADHD group than in the control group p0.012, p0.000, p0.001, respectively. No significant difference was found in the intergroup comparison for MBP p0.181. Conclusion: Increased levels of S100B, NSE, GFAP may be an indicator of neuronal or glial changes in ADHD. Future studies combining serial measurements of these biochemical proteins with genetics and neuroimaging data are needed to evaluate the possible role of glial and neuronal damage in the etiopathogenesis of ADHD.

 Amaç: Bu çalışmanın amacı glial ve nöral yapıyı yansıtan S100B proteini, Nöron Spesifik Enolaz NSE, Miyelin Bazik Protein MBP ve Glial Fibriller Asidik Protein GFAP serum düzeylerini araştırmaktır. Bugüne kadar bu proteinler nöropsikiyatrik hastalıklarda çalışılmış ve nöronal hasarla ilişkisi gösterilmiştir. Ancak bu proteinlerin serum düzeylerini DEHBli çocuklarda eş zamanlı olarak değerlendirerek sağlıklı kontroller ile karşılaştıran bir çalışma mevcut değildir. Gereç ve yöntem: Çalışmaya 44 DEHBli ve 37 sağlıklı gönüllü katımıştır. Katılımcılar, başka tıbbi veya psikiyatrik hastalık öyküsü olmayan ve son altı aydır psikotropik ilaç kullanmayan 6-18 yaş arası çocuk ve gençler arasından seçilmiştir. Serum protein seviyeleri enzim-bağlı immünosorbent yöntemi ELISA ile değerlendirilmiştir. Bulgular: S100B, NSE ve GFAP serum düzeyleri, DEHB grubunda kontrol grubundan istatistiksel olarak anlamlı düzeyde yüksek bulunmuştur sırasıyla p0,012, p0,000, p0,001. MBP için gruplar arası karşılaştırmada anlamlılık düzeyinde bir farklılık saptanmamıştır p0,181. Sonuç: S100B, NSE, GFAPnin yükselmiş düzeyleri DEHBdeki nöronal veya glial değişikliklerin bir göstergesi olabilir. DEHB etiyopatogenezinde glial ve nöronal hasarın olası rolünü değerlendirmek için bu biyokimyasal proteinlerin seri ölçümlerini genetik ve nörogörüntüleme verileriyle birleştiren gelecek çalışmalara ihtiyaç vardır.

Makale detayları

Evaluation of S100B, NSE, MBP and GFAP serum levels in children with attention deficit hyperactivity disorder

Yazarlar:

Hatice Çelik Yıldırım | Bürge Kabukçu Başay | Egem Burcu Ünal

Yayıncı:

Pamukkale University

Ana Başlıklar:

Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları

Dergi:

Pamukkale Tıp Dergisi Vol.18 Issue 2, pp.432-443

Belge Tipi:

Makale

Yayın Tarihi:

1/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001322761

pISSN:

1308-0865

ADHD

glia

astrocyte

neuroinflammationDEHB

glia

astrosit

nöroinflamasyon

Sayı

Makale detayları

Yazarlar: Hatice Çelik Yıldırım | Bürge Kabukçu Başay | Egem Burcu Ünal

Yayıncı: Pamukkale University

Ana Başlıklar: Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları

Dergi: Pamukkale Tıp Dergisi Vol.18 Issue 2, pp.432-443

Belge Tipi: Makale

Yayın Tarihi: 1/2025

Belge Dili: İngilizce

Document ID (Org No.): 2001322761

pISSN: 1308-0865

Sayı

Yazarlar:

Hatice Çelik Yıldırım | Bürge Kabukçu Başay | Egem Burcu Ünal

Yayıncı:

Pamukkale University

Ana Başlıklar:

Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları

Dergi:

Pamukkale Tıp Dergisi Vol.18 Issue 2, pp.432-443

Belge Tipi:

Makale

Yayın Tarihi:

1/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001322761

pISSN:

1308-0865